US 7622610
Crystalline ACAT inhibitor
granted A61KA61K31/16A61P
Quick answer
US patent 7622610 (Crystalline ACAT inhibitor) held by Graceway Pharmaceuticals. LLC expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Graceway Pharmaceuticals. LLC
- Grant date
- Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/16, A61P, A61P17/00, A61P17/08